Literature DB >> 32611574

ABL-class fusion positive acute lymphoblastic leukemia: can targeting ABL cure ALL?

Thai Hoa Tran1, Stephen P Hunger2.   

Abstract

Entities:  

Year:  2020        PMID： 32611574      PMCID： PMC7327627          DOI： 10.3324/haematol.2020.252916

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  18 in total

1.  Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.

Authors:  Shalini C Reshmi; Richard C Harvey; Kathryn G Roberts; Eileen Stonerock; Amy Smith; Heather Jenkins; I-Ming Chen; Marc Valentine; Yu Liu; Yongjin Li; Ying Shao; John Easton; Debbie Payne-Turner; Zhaohui Gu; Thai Hoa Tran; Jonathan V Nguyen; Meenakshi Devidas; Yunfeng Dai; Nyla A Heerema; Andrew J Carroll; Elizabeth A Raetz; Michael J Borowitz; Brent L Wood; Anne L Angiolillo; Michael J Burke; Wanda L Salzer; Patrick A Zweidler-McKay; Karen R Rabin; William L Carroll; Jinghui Zhang; Mignon L Loh; Charles G Mullighan; Cheryl L Willman; Julie M Gastier-Foster; Stephen P Hunger
Journal:  Blood       Date:  2017-04-13       Impact factor: 22.113

2.  Tyrosine kinase inhibitor therapy induces remission in a patient with refractory EBF1-PDGFRB-positive acute lymphoblastic leukemia.

Authors:  Brent W Weston; Melissa A Hayden; Kathryn G Roberts; Susan Bowyer; Johann Hsu; George Fedoriw; Kathleen W Rao; Charles G Mullighan
Journal:  J Clin Oncol       Date:  2013-07-08       Impact factor: 44.544

3.  High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults.

Authors:  Kathryn G Roberts; Zhaohui Gu; Debbie Payne-Turner; Kelly McCastlain; Richard C Harvey; I-Ming Chen; Deqing Pei; Ilaria Iacobucci; Marcus Valentine; Stanley B Pounds; Lei Shi; Yongjin Li; Jinghui Zhang; Cheng Cheng; Alessandro Rambaldi; Manuela Tosi; Orietta Spinelli; Jerald P Radich; Mark D Minden; Jacob M Rowe; Selina Luger; Mark R Litzow; Martin S Tallman; Peter H Wiernik; Ravi Bhatia; Ibrahim Aldoss; Jessica Kohlschmidt; Krzysztof Mrózek; Guido Marcucci; Clara D Bloomfield; Wendy Stock; Stephen Kornblau; Hagop M Kantarjian; Marina Konopleva; Elisabeth Paietta; Cheryl L Willman; Charles G Mullighan
Journal:  J Clin Oncol       Date:  2016-11-21       Impact factor: 44.544

4.  Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.

Authors:  Stephen P Hunger; Xiaomin Lu; Meenakshi Devidas; Bruce M Camitta; Paul S Gaynon; Naomi J Winick; Gregory H Reaman; William L Carroll
Journal:  J Clin Oncol       Date:  2012-03-12       Impact factor: 44.544

5.  Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements.

Authors:  Ilaria Tanasi; Ibrahima Ba; Nicolas Sirvent; Thorsten Braun; Wendy Cuccuini; Paola Ballerini; Nicolas Duployez; Aline Tanguy-Schmidt; Jérôme Tamburini; Sébastien Maury; Eric Doré; Chantal Himberlin; Cédric Duclos; Patrice Chevallier; Philippe Rousselot; Massimiliano Bonifacio; Hélène Cavé; André Baruchel; Hervé Dombret; Jean Soulier; Judith Landman-Parker; Nicolas Boissel; Emmanuelle Clappier
Journal:  Blood       Date:  2019-10-17       Impact factor: 22.113

6.  A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study.

Authors:  Monique L Den Boer; Marjon van Slegtenhorst; Renée X De Menezes; Meyling H Cheok; Jessica G C A M Buijs-Gladdines; Susan T C J M Peters; Laura J C M Van Zutven; H Berna Beverloo; Peter J Van der Spek; Gaby Escherich; Martin A Horstmann; Gritta E Janka-Schaub; Willem A Kamps; William E Evans; Rob Pieters
Journal:  Lancet Oncol       Date:  2009-01-08       Impact factor: 41.316

7.  Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10-14 years as compared with those aged 15-17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study.

Authors:  Anna Maria Testi; Andishe Attarbaschi; Maria Grazia Valsecchi; Anja Möricke; Gunnar Cario; Felix Niggli; Daniela Silvestri; Peter Bader; Michaela Kuhlen; Rosanna Parasole; Maria Caterina Putti; Peter Lang; Christian Flotho; Georg Mann; Carmelo Rizzari; Elena Barisone; Franco Locatelli; Christin Linderkamp; Melchior Lauten; Meinolf Suttorp; Martin Zimmermann; Guiseppe Basso; Andrea Biondi; Valentino Conter; Martin Schrappe
Journal:  Eur J Cancer       Date:  2019-10-17       Impact factor: 9.162

8.  Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  M Aricò; M G Valsecchi; B Camitta; M Schrappe; J Chessells; A Baruchel; P Gaynon; L Silverman; G Janka-Schaub; W Kamps; C H Pui; G Masera
Journal:  N Engl J Med       Date:  2000-04-06       Impact factor: 91.245

9.  Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial.

Authors:  Andrea Biondi; Virginie Gandemer; Paola De Lorenzo; Gunnar Cario; Myriam Campbell; Anders Castor; Rob Pieters; André Baruchel; Ajay Vora; Veronica Leoni; Jan Stary; Gabriele Escherich; Chi-Kong Li; Giovanni Cazzaniga; Hélène Cavé; Jutta Bradtke; Valentino Conter; Vaskar Saha; Martin Schrappe; Maria Grazia Valsecchi
Journal:  Lancet Haematol       Date:  2018-12       Impact factor: 18.959

10.  EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications.

Authors:  Claire Schwab; Sarra L Ryan; Lucy Chilton; Alannah Elliott; James Murray; Stacey Richardson; Christopher Wragg; John Moppett; Michelle Cummins; Oliver Tunstall; Catriona A Parker; Vaskar Saha; Nicholas Goulden; Ajay Vora; Anthony V Moorman; Christine J Harrison
Journal:  Blood       Date:  2016-02-12       Impact factor: 22.113
View more
  1 in total

Review 1.  Genomic Analyses of Pediatric Acute Lymphoblastic Leukemia Ph+ and Ph-Like-Recent Progress in Treatment.

Authors:  Agnieszka Kaczmarska; Patrycja Śliwa; Joanna Zawitkowska; Monika Lejman
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.